{"jsonapi":{"version":"1.0"},"data":{"type":"recalls","id":"f3a990a190ee36f8a1383b5631d5c6ec27f40d434689eee6c69a4c6953ad7466","attributes":{"feedName":"fda","feedSource":"fda","title":"Voluntary Recall of Morphine Sulfate 0.5 mg/mL Preservative Free in 0.9% Sodium Chloride - Pharmakon Pharmaceuticals","description":"The U.S. Food and Drug Administration is alerting health care professionals of a voluntary recall of morphine sulfate 0.5 mg/mL preservative free in 0.9% sodium chloride, 1 mL syringe, CII, for intravenous use made and distributed by Pharmakon Pharmaceuticals, in Noblesville, Indiana, because the product is super-potent. Pharmakon initiated the voluntary recall on February 11, 2016, after receiving laboratory results showing the product was super-potent.","link":"https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/voluntary-recall-morphine-sulfate-05-mgml-preservative-free-09-sodium-chloride-pharmakon","publicationDate":"2019-04-28T23:09:18.000Z","state":"sent","affected":[],"allergens":[],"audience":["professionals"],"categories":["drugs"],"contaminants":[],"distribution":["IL","IN"],"risk":"probable","token":"5d9e68c88b079e002a251a62"}}}